Analysts who follow Catalyst Pharmaceuticals Inc (CPRX) on average expect it to climb 109.04% over the next twelve months. Those same analysts give the stock an average rating of Strong Buy.
That average rating earns Catalyst Pharmaceuticals Inc an Analyst Ranking of 79, which means it ranks higher than 79 of stocks, based on data compiled by InvestorsObserver.
Why are Analyst Ratings Important?
Analytical research by professionals can be extremely useful when making investment decisions in the stock market. Analysts are able to observe industries in detail and learn how geographical impacts can affect a company's balance sheet. This information allows investors to make decisions ahead of the curve.
InvestorsObserver combines the ratings from these analysts and proceeds to percentile rank them. This grants you the ability to compare stocks in a comprehensive fashion as oppossed to a standard buy/hold/sell rating.
What's Happening With Catalyst Pharmaceuticals Inc Stock Today?
Catalyst Pharmaceuticals Inc (CPRX) stock is trading at $3.54 as of 11:23 AM on Tuesday, Jan 12, a gain of $0.09, or 2.61% from the previous closing price of $3.45. The stock has traded between $3.47 and $3.67 so far today. Volume today is low. So far 1,020,269 shares have traded compared to average volume of 1,975,703 shares.
Click Here to get the full report on Catalyst Pharmaceuticals Inc (CPRX) Stock.
